XML 25 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 7 - Equity and Equity-based Compensation
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Members' Equity Notes Disclosure [Text Block]
7.
         Equity and Equity-Based Compensation
 
At
December 31, 2016,
Ramaco Development, LLC had
8,000,000
common units and
4,538,836
preferred units issued and outstanding. On
February 8, 2017,
in connection with the Company
’s IPO, a corporate reorganization occurred and each unit of Ramaco Development, LLC was converted into approximately
2.81
shares of common stock in Resources and as a result, the Company issued
35,262,576
shares of common stock. The Company issued an additional
3,800,000
shares of common stock in the IPO. After the corporate reorganization and the completion of the IPO discussed above, the Company is authorized to issue up to a total of
260,000,000
shares of its common stock with a par value
$0.01
per share, and
50,000,000
shares of its preferred stock with a par value of
$0.01
per share. Holders of our common stock are entitled to
one
vote for each share held of record on all matters submitted to a vote of stockholders and to receive ratably in proportion to the shares of common stock held by them any dividends declared from time to time by the board of directors. Our common stock has
no
preferences or rights of conversion, exchange, pre-exemption or other subscription rights. At
September 30, 2017,
we had
39,509,311
shares of our common stock issued and outstanding. We had
no
preferred shares issued or outstanding at
September 30, 2017.
 
  
Equity-Based Compensation
—On
August 31, 2016,
Ramaco Development, LLC granted
two
executives an aggregate of
333,334
options (
166,667
each) for the purchase of common units at an exercise price of
$15
per unit. The options have a
ten
-year term from the grant date. The options to purchase common units were converted into
937,424
options to purchase shares of the Company’s common stock. Vesting of these options was accelerated in our IPO pursuant to their terms. The Company recognized the remaining
$2,144,333
of equity-based compensation expense during the
three
months ended
March 31, 2017
for this accelerated vesting.
 
On
June 28, 2017,
the Company granted a total of
446,735
shares of restricted stock awards to
six
executives and the
three
independent directors. The fair market value, based on the closing price of the stock on the day of the grant, was
$5.82
per share. The awards to the executives vest in full on
December 31, 2019
and the awards to the independent directors vest in full on
December 31, 2017.
The Company will recognize
$2,600,000
in equity-based compensation through the vesting dates. The Company has assumed
zero
forfeitures. The Company recognized
$320,007
of equity-based compensation expense during the
three
months ended
September 30, 2017
for these awards.